These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 894490)

  • 1. Kinetics of drug-drug interactions in sheep: tolbutamide and sulfadimethoxine.
    Thiessen JJ; Rowland M
    J Pharm Sci; 1977 Aug; 66(8):1063-70. PubMed ID: 894490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Displacing effects of chenodeoxycholic acid, ursodeoxycholic acid and sulfadimethoxine on plasma protein binding of tolbutamide.
    Goto S; Watanabe S; Maehara S; Nakata Y; Tateyama T
    J Pharmacobiodyn; 1985 Jun; 8(6):440-7. PubMed ID: 4057039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of acute viral hepatitis on disposition and plasma binding of tolbutamide.
    Williams RL; Blaschke TF; Meffin PJ; Melmon KL; Rowland M
    Clin Pharmacol Ther; 1977 Mar; 21(3):301-9. PubMed ID: 837649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic analysis of tolbutamide-sulfonamide interaction in rabbits based on clearance concept. Prediction of species difference from in vitro plasma protein binding and metabolism.
    Sugita O; Sawada Y; Sugiyama Y; Iga T; Hanano M
    Drug Metab Dispos; 1984; 12(1):131-8. PubMed ID: 6141904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of peritoneal dialysis of tolbutamide in rats under conditions of the plasma unbound fraction being increased.
    Makita T; Aiba T; Izuwa Y; Komori Y; Kawasaki H; Kurosaki Y
    Biopharm Drug Dispos; 2009 Jan; 30(1):1-8. PubMed ID: 19148953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiologically based pharmacokinetics of drug-drug interaction: a study of tolbutamide-sulfonamide interaction in rats.
    Sugita O; Sawada Y; Sugiyama Y; Iga T; Hanano M
    J Pharmacokinet Biopharm; 1982 Jun; 10(3):297-316. PubMed ID: 7175701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of drug-drug interaction from in vitro plasma protein binding and metabolism. A study of tolbutamide-sulfonamide interaction in rats.
    Sugita O; Sawada Y; Sugiyama Y; Iga T; Hanano M
    Biochem Pharmacol; 1981 Dec; 30(24):3347-54. PubMed ID: 7326045
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of total plasma concentration and age on tolbutamide plasma protein binding.
    Adir J; Miller AK; Vestal RE
    Clin Pharmacol Ther; 1982 Apr; 31(4):488-93. PubMed ID: 7060330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of sulphinpyrazone on oxidative drug metabolism in man: inhibition of tolbutamide elimination.
    Miners JO; Foenander T; Wanwimolruk S; Gallus AS; Birkett DJ
    Eur J Clin Pharmacol; 1982; 22(4):321-6. PubMed ID: 7106168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of in vivo drug-drug interactions between tolbutamide and various sulfonamides in humans based on in vitro experiments.
    Komatsu K; Ito K; Nakajima Y; Kanamitsu Si; Imaoka S; Funae Y; Green CE; Tyson CA; Shimada N; Sugiyama Y
    Drug Metab Dispos; 2000 Apr; 28(4):475-81. PubMed ID: 10725317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tenidap sodium does not alter the clearance or plasma protein binding of tolbutamide in healthy male volunteers.
    Wilner KD; Gardner MJ
    Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):39S-42S. PubMed ID: 7547093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cotrimoxazole as an inhibitor of oxidative drug metabolism: effects of trimethoprim and sulphamethoxazole separately and combined on tolbutamide disposition.
    Wing LM; Miners JO
    Br J Clin Pharmacol; 1985 Nov; 20(5):482-5. PubMed ID: 3878154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of inhibition of tolbutamide hydroxylation by cimetidine in man.
    Stockley C; Keal J; Rolan P; Bochner F; Somogyi A
    Eur J Clin Pharmacol; 1986; 31(2):235-7. PubMed ID: 3803421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of diphenylhydantoin (DPH) and tolbutamide in man.
    Wesseling H; Mols-Thürkow I
    Eur J Clin Pharmacol; 1975; 8(1):75-8. PubMed ID: 1233204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of sulfadimethoxine on thiopental distribution and elimination in rats.
    Yu HY; Sawada Y; Sugiyama Y; Iga T; Hanano M
    J Pharm Sci; 1981 Mar; 70(3):323-6. PubMed ID: 7264902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Displacing effect of serum protein binding on intestinal absorption of sulfadimethoxine].
    Imamura Y; Agemura H; Otagiri M
    Yakugaku Zasshi; 1989 Jan; 109(1):65-70. PubMed ID: 2732906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition of sulfadimethoxine in swine: inclusion of protein binding factors in a pharmacokinetic model.
    Bevill RF; Koritz GD; Rudawsky G; Dittert LW; Huang CH; Hayashi M; Bourne DW
    J Pharmacokinet Biopharm; 1982 Oct; 10(5):539-50. PubMed ID: 7166737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic studies on drug disposition in rabbits. III. Effect of tolbutamide on renal excretion of sulfamethizole.
    Katayama K; Ohtani H; Mizuno H; Taniguchi T; Kakemi M; Koizumi T
    J Pharmacobiodyn; 1990 Feb; 13(2):120-9. PubMed ID: 2384848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of sulfadimethoxine in cats.
    Baggot JD
    Aust J Exp Biol Med Sci; 1977 Dec; 55(6):663-70. PubMed ID: 614834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative pharmacokinetics of coumarin anticoagulants XXXVII: Simultaneous in vivo displacement of dicumarol from serum protein and tissue binding sites by tolbutamide in rats.
    Lai CM; Levy G
    J Pharm Sci; 1978 Oct; 67(10):1492-3. PubMed ID: 81299
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.